Crossmark Global Holdings, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$372
-1.3%
4,019
-1.0%
0.01%0.0%
Q2 2023$377
+5.3%
4,060
-6.4%
0.01%0.0%
Q1 2023$358
+8.5%
4,336
+3.5%
0.01%0.0%
Q4 2022$330
-99.9%
4,188
+2.0%
0.01%0.0%
Q3 2022$304,000
+5.9%
4,105
-6.9%
0.01%
+14.3%
Q2 2022$287,000
+2.9%
4,410
-0.2%
0.01%
+16.7%
Q1 2022$279,000
+19.2%
4,420
+0.2%
0.01%
+20.0%
Q4 2021$234,000
-14.9%
4,410
+13.1%
0.01%
-16.7%
Q3 2021$275,000
+5.4%
3,900
-0.5%
0.01%0.0%
Q2 2021$261,000
-46.2%
3,920
-10.3%
0.01%
-50.0%
Q1 2021$485,000
-6.9%
4,370
-0.5%
0.01%
-7.7%
Q4 2020$521,000
+32.2%
4,390
-2.9%
0.01%
+18.2%
Q3 2020$394,000
-5.3%
4,520
-2.8%
0.01%
-8.3%
Q2 2020$416,000
-0.2%
4,650
+11.2%
0.01%
-20.0%
Q1 2020$417,000
-14.5%
4,180
-1.6%
0.02%
+15.4%
Q4 2019$488,000
-23.0%
4,250
-15.5%
0.01%
-31.6%
Q3 2019$634,000
-0.2%
5,030
-4.7%
0.02%
+5.6%
Q2 2019$635,000
+28.8%
5,280
-6.4%
0.02%
+28.6%
Q1 2019$493,000
-11.2%
5,639
+1.6%
0.01%
-17.6%
Q4 2018$555,000
+4.9%
5,549
+20.1%
0.02%
+30.8%
Q3 2018$529,000
+26.0%
4,619
-1.3%
0.01%
+18.2%
Q2 2018$420,000
-29.4%
4,679
-42.4%
0.01%
-26.7%
Q1 2018$595,000
+1.7%
8,129
-19.3%
0.02%
+7.1%
Q4 2017$585,000
+32.4%
10,078
+2.3%
0.01%
+27.3%
Q3 2017$442,0000.0%9,8490.0%0.01%0.0%
Q3 2016$442,0009,8490.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders